N@N

Finkelstein Thompson LLP Announces Investigation of Continucare Corporation

^{Published on 2011-06-27 10:00:46 - Market Wire}
 

WASHINGTON--([ BUSINESS WIRE ])--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Continucare Corporation (aContinucarea or the aCompanya) (NYSE: CNU) concerning the proposed acquisition of the Company by Metropolitan Health Networks, Inc. (aMetropolitana) (NYSE AMEX: MDF). Under the terms of the transaction, Continucarea™s shareholders would receive $6.25 per share in cash. Shareholders would also receive 0.0414 of a share of Metropolitan common stock for each share they own, presently valued at approximately $0.19.

The investigation is focused on the potential unfairness of the consideration to Continucare shareholders, the process by which the Companya™s Board of Directors considered the transaction, and potential conflicts of interests among Continucare Board members.

If you are interested in discussing your rights as a Continucare shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at [ contact@finkelsteinthompson.com ].

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.

To learn more about Finkelstein Thompson LLP, please visit our web site at [ www.finkelsteinthompson.com ]. Attorney advertising. Prior results do not guarantee similar outcomes.